MedTrace Logo

The Gastric HormonE BioMarkers of Preneoplastic Lesions Study

NCT06085677 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-10-17

No results posted yet for this study

Summary

The goal of the study is to understand whether blood levels of hormones produced or metabolized in the stomach reflect the health of the stomach lining.

Specifically the study will determine whether the concentration of ghrelin, gastrin, pepsinogens and vitamin B12 reflect the condition of the stomach lining. Hormone concentrations for people with normal/mild gastritis will be compared to people with long-term inflammation of the stomach (chronic atrophic gastritis), and people with pre-cancerous cellular changes (intestinal metaplasia).

Conditions

  • Stomach Neoplasm
  • Chronic Atrophic Gastritis
  • Intestinal Metaplasia

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • University of Copenhagen

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Gwen Murphy, PhD MPH · Imperial College Dublin

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-04
Primary Completion
2024-09-02
Completion
2024-09-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06085677 on ClinicalTrials.gov